Clinical Trial Update: Stereotactic Biopsy Split-Course Radiation Therapy in Diffuse Midline Glioma, SPORT-DMG Study [Phase 2]

View source ↗

Summary

A Phase 2 Mayo Clinic trial is evaluating stereotactic biopsy followed by split-course radiation therapy for diffuse midline glioma with H3 K27M mutation. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Midline Glioma H3 K27m-mutant

Snippet

Sponsor: Mayo Clinic | Conditions: Diffuse Midline Glioma, H3 K27M-Mutant | Phase 2 | Status: RECRUITING